Skip to main content
Clinical Trials/NCT05509036
NCT05509036
Completed
Not Applicable

Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients (FORECAST) Multi-Center Study

Dr. John Muscedere11 sites in 1 country700 target enrollmentSeptember 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Frailty
Sponsor
Dr. John Muscedere
Enrollment
700
Locations
11
Primary Endpoint
Frailty status
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

A prospective observational study of critically ill patients over the age of 50, studying the occurrence of frailty as measured by a variety of frailty measures, processes of care and long term outcomes.

Detailed Description

Frailty is common in critically ill elderly patients, and is associated with adverse impacts on outcomes and is becoming increasingly common in Intensive Care Unit (ICU) populations. However it is not clear as to how to best measure frailty and when to do so. It is also not clear as to how processes of care impact on the outcomes observed. We hypothesize that frailty in survivors of critical illness will be measurable at hospital discharge, will correlate with processes of care while in ICU and will better discriminate long term outcomes when compared to severity of illness or the degree of frailty present on ICU admission.

Registry
clinicaltrials.gov
Start Date
September 1, 2019
End Date
June 1, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Dr. John Muscedere
Responsible Party
Sponsor Investigator
Principal Investigator

Dr. John Muscedere

Professor of Medicine

Queen's University

Eligibility Criteria

Inclusion Criteria

  • Must Meet both 1 and 2
  • Age \> 50 years. We have selected \>50 years in keeping with prior descriptions of critically ill patients \[17\].
  • Receipt of at least one of the following life support interventions for over 24 hours:
  • Mechanical ventilation: Both invasive and non-invasive either solely or in combination are acceptable. High flow oxygen (e.g. OPTIFLOW) as a form of Non-Invasive Ventilation (NIV) is acceptable but the patient's Fraction of Inspired Oxygen (FIO2) at the time of enrollment must be greater \> 50%.
  • Vasoactive medications (vasopressors or inotropes).
  • Acute renal replacement therapy (RRT). Patient must have been admitted to ICU for the receipt of renal replacement therapy, either intermittent or continuous and after 24 hours of ICU admission, there is a continued need for further RRT.

Exclusion Criteria

  • ICU admission greater than 5 days at the time of enrollment.
  • Expected to survive for less than 72 hours after study enrollment.
  • No family or caregivers available to collect collateral history.
  • Family or caregivers not able to speak English or French.
  • Projected inability to complete 6 month follow-up either by telephone or in-person.

Outcomes

Primary Outcomes

Frailty status

Time Frame: 6 Months

Frailty as measured with the Frailty Index (FI). The FI is indicated by the proportion of deficits present over the number measured and is scored as a fraction between 0 and 1.0. Frailty is considered to be present when the FI is \> 0.20 and the severity of frailty is considered higher with increasing values for the FI.

Secondary Outcomes

  • Correlation of ICU processes of care (nutritional adequacy, adverse events, mobilization and sedation) with frailty progression as measured by the Clinical Frailty Scale or Frailty Index(28 days)
  • Impact of admission critical illness on the development and severity of frailty as measured by a Frailty Index or Clinical Frailty Scale(28 days and 6 months)
  • Correlation of frailty severity at hospital discharge with long term outcomes (mortality, Quality of Life and Need for Institutionalization)(6 months)
  • Number of patients with a measure of frailty prior to hospital discharge.(28 days)

Study Sites (11)

Loading locations...

Similar Trials